AIRNA
Pre-clinicalA bold visionfor genetic medicines AIRNA is committed to delivering the promise of RNA editing to people with rare diseases and common conditions The
Founded
2021
Focus
RNA TherapeuticsOncology
About
A bold visionfor genetic medicines AIRNA is committed to delivering the promise of RNA editing to people with rare diseases and common conditions The
Funding History
5Total raised: $253.6M
Series B$155MUndisclosedApr 1, 2025
Series A$60MUndisclosedJul 31, 2024
PIPE$30MUndisclosedSep 19, 2023
Seed$4.3MUndisclosedMar 15, 2023
Company Info
TypePrivate
Founded2021
LocationHamburg, Germany
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile